SEP 10, 2026 · PHASE 3 TRIAL
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
ClinicalTrials.gov
This is a completed phase 3 trial registration with no results posted; the primary outcome measure and follow-up duration are listed but no efficacy or safety data are reported in this registry record.
Reported
Planned enrollment731
Primary outcome measureOverall Survival Time
Follow-up duration11.25 years